UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Tortoise Investment Management LLC

Tortoise Investment Management LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 34.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 483 shares of the healthcare conglomerate’s stock after purchasing an additional 123 shares during the quarter. Tortoise Investment Management LLC’s holdings in UnitedHealth Group were worth $254,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the company. Richelieu Gestion SA purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $26,000. CGC Financial Services LLC increased its stake in shares of UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 50 shares during the period. True Wealth Design LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $31,000. LFA Lugano Financial Advisors SA increased its stake in UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 40 shares during the last quarter. Finally, O Brien Wealth Partners LLC increased its stake in UnitedHealth Group by 36.8% in the fourth quarter. O Brien Wealth Partners LLC now owns 78 shares of the healthcare conglomerate’s stock valued at $41,000 after purchasing an additional 21 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages have commented on UNH. Royal Bank of Canada dropped their price target on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 17th. Piper Sandler increased their price objective on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price objective for the company in a report on Wednesday, June 5th. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a report on Wednesday. Finally, Robert W. Baird assumed coverage on UnitedHealth Group in a report on Thursday, May 30th. They issued an “outperform” rating and a $597.00 price objective for the company. Two analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $579.74.

UnitedHealth Group Price Performance

UnitedHealth Group stock traded down $0.18 during midday trading on Friday, reaching $497.12. 3,188,374 shares of the company were exchanged, compared to its average volume of 3,452,273. The company has a market capitalization of $457.54 billion, a price-to-earnings ratio of 30.39, a P/E/G ratio of 1.44 and a beta of 0.58. The firm’s 50-day simple moving average is $493.55 and its 200-day simple moving average is $506.38. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. During the same quarter last year, the business posted $6.26 EPS. The firm’s quarterly revenue was up 8.6% compared to the same quarter last year. On average, analysts anticipate that UnitedHealth Group Incorporated will post 27.57 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th will be paid a dividend of $2.10 per share. The ex-dividend date is Monday, June 17th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.69%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.